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it. The global agribusiness company 
Syngenta, which was set up in 2000 in 
the merger of the agricultural divisions 
of Novartis and AstraZeneca, also 
supports the project.
Principal investigator Maarten Van 
Helden from the National School for 
Agricultural Engineers at Bordeaux 
has been running the project for 
around two years with his research 
staff and Syngenta employees, but 
this year, volunteers from the general 
public recruited by Earthwatch will be 
participating for the first time. 
Viticulture in places like the 
Bordeaux region is ideally suited 
for the development and study of 
sustainable agriculture, as its primary 
focus is not on quantity but on 
quality and character. The natural 
environment around vineyards, 
known as the ‘terroir’ helps to create 
the specific character of a wine. 
Therefore, wine growers have a 
strong interest in preserving or even 
enhancing the terroir, which could 
be defined by elements such as 
hedgerows, small forests, or rivers 
and lakes. Van Helden’s project aims 
at a better understanding of the 
biodiversity in such environments and 
providing farmers with new ideas as to 
how they might enhance it. 
The hope is that natural biodiversity, 
possibly including species that 
were lost and then reintroduced, will 
contribute to a natural regulation 
of vine pests and will also help to 
prevent erosion and land degradation, 
and avoid run-off of fertilisers and 
pesticides. While some “farmscaping” 
measures have already been tried in 
some areas and are recommended 
in farming guidelines, their success 
needs to be monitored in the long 
term, such that future measures can 
be based on solid scientific evidence.
When reconsidering their production 
methods, wine growers will also 
be able to benefit from the recent 
publication of the complete genome 
sequence of the Pinot Noir grapevine. 
Anne-Françoise Adam- Blondon, 
who was involved in the sequencing 
work, commented on the biodiversity 
project: “I think that it is a very 
interesting objective; in parallel it 
could be interesting to introduce 
more diversity in terms of grapevine 
cultivars.”
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web 
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Jeff Hall was born in Brooklyn, New 
York, but spent most of his childhood 
years in the suburbs of Washington, 
DC. He was an undergraduate at 
Amherst College in Massachusetts, 
where he began to study genetic 
phenomena in Drosophila. He 
continued in this vein as a graduate 
student at the University of 
Washington (Seattle). When he 
subsequently became a postdoctoral 
researcher at the California Institute 
of Technology (Pasadena, California), 
he made a lateral move into 
neurogenetic studies of Drosophila 
(just as a duck might make a lateral 
move à l’orange). After his CalTech 
stint, he returned to Massachusetts 
to become a faculty member at 
Brandeis University (Waltham), where 
he has spent almost all his time from 
1974 to the present. He has also 
faked some work at the University 
of Maine (Orono), off and on during 
the current century. Throughout 
most of Hall’s career, studies 
performed by him and co-workers 
have involved genetic, molecular 
and neurobiological analyses of 
reproductive behavior in Drosophila, 
as well as analogous investigations 
of the fruit-fly’s biological 
rhythms — along with ways that 
those two phenomena overlap by 
virtue of certain gene actions. 
Who had important positive 
effects on your formative years? 
A key early influence was Philip 
Ives, my first mentor. When I was 
an undergraduate, Ives was a 
sub- faculty researcher. He went  
deaf when he was a student of  
A.H. Sturtevant in the 1930s, making 
it difficult for him to secure a standard 
job. So he was given an ostensible 
‘charity’ position at the little college 
in question (even though he was 
one of the few serious biological 
researchers there). I was assigned to 
Ives as a research assistant. He was 
a superbly dedicated trainer, from 
whom I learned many nuts and bolts 
about Drosophila genetics. Just as 
important, Dr. Ives encouraged me 
to ‘love the little flies’ — implying 
one must feel that way to get the 
most out of one’s organism. This 
Q & A view resonated with me, for I realized that I did love working with them in 
general and during a given moment. 
Many years later, I noticed that 
some of those who started studying 
Drosophila seemed at best indifferent 
to the little flies and even seemed 
to fight them, which conceivably 
undermined the quality of their 
research.
Another important mentor was, 
oddly, a chairman: Herschel Roman, 
founder and longtime chair of a 
seminal Genetics department, 
in which I was fortunate to be a 
graduate student. He made that 
research group into a tribal entity, 
fostering relentlessly positive 
interactions amongst its members 
(beyond mere camaraderie and 
carousing). Roman also took many 
of the individual trainees in his 
department under his wing and 
routinely informed himself about 
what we were doing experimentally. 
He provided superb guidance for our 
activities as nascent professionals 
and even made specific research 
recommendations from time to 
time. I was not, and should not 
have been, singled out for Roman’s 
attentions. But I appreciated his 
awareness of me, which included 
that Herschel catalyzed scenarios 
by which I received offers for both 
postdoctoral and faculty positions. 
Years later, my admiration of him 
grew, as I realized how special he 
was as a biologist in general and a 
leader in particular. Prof. Roman was 
the opposite of ‘chairman as empty 
suit.’ Among those operating at that 
high level whom I have encountered 
since, few have offered his kind of 
close support for the people they’re 
supposed to lead.
Do you have any other ‘heroes,’ 
as it were, among researchers 
in your field? Yes, two stand out; 
like Ives and Roman, they are 
pretty- much unheard-of by now. 
One is Douglas Kankel, a co-post 
doc of mine. Doug and I worked 
side- by- side on two neurogenetic 
projects using Drosophila. He was 
one of the most insightful critics 
I’ve known; but he displayed this 
attitude with deep knowledge and 
sharp wit, never by way of pure 
naysaying. Kankel opened my eyes 
to the potential of the little flies. I had 
been laboring in the micro-arena that 
could be called ‘genetic genetics,’ 
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one takes the approach just implied 
to analyze a biological phenomenon. 
Doug stressed the importance of 
adopting a self-demanding attitude, 
in which one must assimilate many 
kinds of biological knowledge to 
apply to the problem at hand, no 
matter how formidable the disparate 
pieces of expertise may be.
The second idol I’ll mention is 
David Suzuki. He got into genetics 
at the same college where I did, 
although we did not overlap. I 
was fortunate to meet Suzuki as a 
graduate student, when he was at 
the University of British Columbia. 
His work was crucial to the 
resurrection of Drosophila from the 
ash heap of biological research. Back 
then, most of the work in the fly was 
genetic genetics, addressing ever 
more narrow and esoteric questions. 
Herschel Roman would come into 
the lab where I toiled as a graduate 
student and (jocularly) pronounce 
that ‘you folks are working in a 
dying system.’ Suzuki contributed 
mightily to turning this around. He 
began systematically to screen for 
developmental mutants in Drosophila 
that were temperature-sensitive. The 
genetic world reacted to Suzuki’s 
approach and accomplishments as 
if they were genuinely sensational. I 
heard a hard-bitten local geneticist 
(not Roman) exclaim that ‘he’s taking 
microbial principles into a metazoan!’ 
More broadly, Suzuki was delivering 
seminar after seminar; and everyone 
wanted to hire him away from UBC. 
But Dave did not bite. During the 
late ‘70s he left university science 
and went into television in his 
native Canada (Suzuki on Science; 
Canadian Broadcasting Corporation), 
where he has sustained this activity 
and analogous ones ever since.
David Suzuki’s contribution to 
resurrecting Drosophila is not well 
enough remembered or recognized. 
His work came to the fore slightly 
in advance of the genetic screens 
performed by Seymour Benzer 
and other drosophilists. Suzuki’s 
conditional mutants began to 
appear in print during the same year 
that Benzer’s seminal search for 
behavioral mutants was reported, 
but the former’s accomplishments 
seemed more significant at the time 
(perhaps because the development 
of animals was taken more seriously 
than their behavior). And these activities occurred well before the 
Nüsslein- Volhard/Wieschaus screen 
for their famed developmental 
body- plan mutants. They shared 
the Nobel Prize with Edward Lewis. 
Before this, only fly people seemed 
aware of Ed’s activities. He once said 
to me, in his mensh-like manner: 
‘Jeff, I don’t publish because of what 
people say, that I’m a perfectionist or 
something; actually I wasn’t getting 
anything done until I started looking 
at embryos expressing bithorax 
variants.’ These of Lewis’s studies 
were picking up steam when I was at 
CalTech, ending in the early ’70s, and 
they culminated later that decade in 
his famous Nature article. (I include 
this apparently stray point as a 
preview about problematical features 
associated with ‘a number’ of other 
articles that appear in rags of this ilk.)
You just alluded to being a 
post- doc with Seymour Benzer. 
Is he not another of your 
heroes? Not really, despite all his 
achievements during a long career, 
ending only with his death at the end 
of last year (an event that saddened 
me greatly). It is rather awkward to 
say this about someone so recently 
deceased, but I feel that Seymour 
was not a leader in the same ways 
as those I’ve pointed out, neither 
to his group nor to the field of 
neurogenetics at large. Indeed, he 
actively disclaimed any leadership 
role. I regret that he did not promote 
the field more strongly. (He might 
have done more than give ‘big  
talks.’) He otherwise shied away from 
using his fame, in that he demurred 
from going to the mat on behalf of 
certain former co-workers when they 
found themselves at crucial tipping 
points in their careers.
You sound especially grumpy 
about scientific luminaries: why? 
I can’t help feel that some of these 
‘stars’ have not really earned their 
status. I wonder whether certain 
such anointees are ‘famous because 
they’re famous.’ So what? Here’s 
what: they receive massive amounts 
of support for their research, 
absorbing funds that might be better 
used by others. As an example, one 
would-be star boasted to me that 
he’d never send a paper from his 
lab to anywhere but Nature, Cell, or 
Science. These submissions always 
get a foot in the door, at least. And they are nearly always published in 
one of those magazines — where, 
when you see something you know 
about, you realize that it’s not always 
so great.
Celebrity ‘PI’s,’ who are no longer 
Professors, have too much in the 
way of lavished resources — by 
which I mean too much money to 
do good work! They can and do hire 
very large numbers of workers, but it 
is at-best difficult closely to interact 
with and properly to supervise these 
bloated numbers of personnel. Such 
Actual Investigators (AIs) cannot 
easily gain their boss’s attention; 
and the latter is unable to provide 
the required close, ongoing scrutiny 
of their research. There is huge 
pressure on the overworked, anxious 
AI to bring something ‘great’ to the 
boss, who wants everything to go 
to a vanity journal. One outcome 
of these antics is that some bizarre 
stuff is salted throughout this overly 
conspicuous subset of the literature.
The implication is that you are not 
graced with the ability to function 
in this manner? Is this true, and 
is it why you are about to leave 
science early? Yes and yes. I admit 
that I resent running out of research 
money. If Seymour and the like are 
(or were) the Dave Singleman’s of 
our business, I am amongst the Willy 
Loman’s. This means, for instance, 
that recent applications from our 
lab have had their lungs ripped out, 
often accompanied by sneering, 
personal denunciations — perhaps 
reflecting the fact that this old-timer 
has lost his touch. But I still love 
the little flies and claim that my 
colleagues and I could continue to 
interact with them productively. 
Whether or not a researcher of 
a certain notoriety deserves that 
the ‘support system’ keep him 
going, there is a far more general 
problem: What props up biological 
research, at least in the vaunted US 
of A, involves a situation so deeply 
imbued with entitlement mentality 
that it has sunk into institutional 
corruption. A principal symptom 
of this state of affairs involves the 
following: People are hired after 
they have undergone long stints of 
training; and a potential hiree must 
present a large body of documented 
accomplishments. In my day you 
could get a faculty job with zero 
post-doc papers, as in the case 
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Yolk
Paul Jorgensen
What is yolk? Yolk is the food 
deposited in the eggs of animals that 
will provide the energy and building 
blocks required for development and 
growth. Yolk comes in different forms, 
but the term ‘yolk’ probably originally 
referred to the familiar amniote  
eggs that give rise to reptiles, birds  
and omelettes.
How is yolk ‘eaten’? In amniotes, 
the embryo forms from cells that sit 
on top of the denser, more opaque 
yolk. As the embryo develops, it 
forms a yolk sac, which acts as 
an extraembryonic gut, taking up 
substances from the yolk, digesting 
them and distributing nutrients to the 
embryo proper via the circulation. 
Many animals (e.g. many insects, 
octopuses, fish, reptiles, marsupial 
mammals) use yolk sacs to feed the 
embryo (Figure 1A). But there are 
also a number of animal groups (e.g. 
nematodes, sea urchins and almost 
all amphibians) that do not develop a 
yolk sac. In such organisms, the yolk 
is less conspicuous and is perhaps 
best defined as the nutritional reserves 
provided by the mother, including yolk 
platelets, fat droplets and glycogen. 
These reserves are inherited from the 
egg cytoplasm by all of the embryonic 
cells and are consumed intracellularly 
during development (Figure 1B,C). The 
patterns mentioned above need not be 
mutually exclusive. During later stages 
of amphibian embryogenesis, for 
instance, the developing gut appears 
to feed the rest of the embryo by 
digesting its intracellular yolk,  
thus functioning much like a yolk  
sac. Conversely, in embryos with yolk 
sacs, a small amount of yolk might 
infiltrate the embryonic cells.
What are yolk platelets? Yolk 
platelets are usually the dominant 
components of yolk. In fact, yolk 
platelets are often the dominant 
components of eggs. In the African 
clawed frog, Xenopus laevis, yolk 
platelets make up 50% of the egg 
volume and 80% of the egg protein. 
Yolk platelets come in a number of 
Quick guide
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Figure 1. Diversity of yolk.
(A) A big ball of yolk underlies the zebrafish 
embryo and is being consumed by a yolk 
sac (Photograph by Steven J. Baskauf). (B) 
In Xenopus embryos, yolk platelets (white 
and/or blue spheres) are prominent in all 
cells early in development. (C) Yolk platelets 
(white spheres) are scattered throughout the 
developing C. elegans embryo. (D) Mosquito 
oocytes contain yolk platelets with central 
crystals of Vitellogenin derivatives (PR). (Re-
produced with permission from Roth, T.F. and 
Porter, K.R. (1964). Yolk protein uptake in the 
oocyte of the mosquito Aedes aegyptii. J. 
Cell Biol. 20, 313–322. Rockefeller University 
Press.)of yours truly; but now the CV of a 
successful applicant looks like that 
of a newly minted full Professor from 
olden times. Notwithstanding these 
demands, and the associated high 
quality of a fledgling faculty- level 
type, the job starts with some 
‘set- up’ money for equipping the lab; 
but next to no means are provided 
to initiate that ‘research program’ 
and to sustain it during the years 
to come. US institutions (possibly 
also those in other countries) 
behave as though they and their 
PIs are entitled to research funding, 
which will magically materialize 
from elsewhere: ‘Get a grant, serf! 
If you can’t do it quickly, or have 
trouble for some years — or if your 
funding doesn’t get renewed, despite 
continuing productivity — forget 
it!’ But what if there are so many 
applicants (as there are nowadays) 
that even a meritorious proposal gets 
the supplicant nowhere or causes a 
research group to grind prematurely 
to a halt? What if the situation is 
worsened when the government at 
hand is anti-science and otherwise 
squanders its resources on 
international adventurism? 
Unlike most professionally 
based endeavors, the business of 
biology gives you only the spatial 
wherewithal to do the work for which 
you were hired. You get nothing for 
the personnel required to function, let 
alone for all the items needed to get 
through a given week of work. Might 
an institution imagine that it should 
devote part of its ‘capital fundraising’ 
toward endowing the ongoing 
research of its employees — at 
least so that no such effort would 
abruptly sink to the null point? The 
answer is ‘nice try: we will raise 
funds, but we’ll put them all into 
building buildings — in order to fill 
them with additional hires, who will 
be as haplessly on-their-own as is 
ill-fated you.’ Having said all this, I 
acknowledge that ‘I got mine’ from 
the government over the course of 
many years. Thus, as I say ‘so long,’ 
one component of my last- gasp 
disquiet stems from pompously 
worrying about biologists who are 
starting out or are in mid- career.
Department of Biology, Brandeis University, 
Waltham, Massachusetts 02454, USA; 
School of Biology and Ecology, University 
of Maine, Orono, Maine 04469, USA.  
E-mail: hall@brandeis.edu, Jeffrey_Hall@
umit.maine.edu
